Target intelligence / Profile preview

MT-CO2 pseudogene 11 (MTCO2P11)

Target
MTCO2P11
Molecular classification
Other (Pseudogene)
01

Overview

MT-CO2 pseudogene 11 (MTCO2P11) is a nuclear pseudogene related to the mitochondrially encoded cytochrome c oxidase II (MT-CO2, also known as COX2, Cytochrome c oxidase subunit II)[2][4][7]. Unlike the functional MT-CO2 gene, which encodes a key subunit of Complex IV in the mitochondrial respiratory chain and is essential for cellular energy production[1][6], MTCO2P11 does not encode a functional protein and is typically considered non-coding "junk DNA"[2][4]. MTCO2P11 is located on chromosome 9 (hg38: chr9:5098341-5099325)[4]. There is no evidence to support its role as a therapeutic target, and there are no known biological functions, disease associations, or known interactions with drugs. The designation as a pseudogene implies MTCO2P11 is generally not transcribed or translated and does not participate in enzymatic, receptor, transporter, or signaling activities relevant to molecular pharmacology[2][7][9]. Pseudogenes are typically remnants of gene duplication or retrotransposition events that have lost their protein-coding capacity and regulatory elements but can sometimes exert regulatory effects via non-coding RNA or act as microRNA decoys[9]. However, for MTCO2P11, no such functions are recognized in the current literature or major genomic databases[2][4][7]. The MT-CO2 gene (not MTCO2P11) codes for a critical mitochondrial enzyme subunit, but the pseudogene variant is not involved in any known biological pathways or disease processes, nor does it serve as a biomarker or safety concern in clinical or pharmacological contexts[1][6][7].

Other names
MTCO2P11MT-CO2 Pseudogene 11

Beyond the preview

Go deeper on MT-CO2 pseudogene 11 (MTCO2P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-CO2 pseudogene 11 (MTCO2P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call